title: Safety and tolerability of iodixanol. A dimeric, nonionic contrast medium: an emphasis on European clinical phases I and II.
authors.affiliation: Clinical R&D, Nycomed AS, Oslo, Norway.
authors.forename: B
authors.initials: B
authors.lastname: Bolstad
authors.forename: K W
authors.initials: KW
authors.lastname: Borch
authors.forename: B H
authors.initials: BH
authors.lastname: Grynne
authors.forename: B
authors.initials: B
authors.lastname: Lundby
authors.forename: J O
authors.initials: JO
authors.lastname: Nossen
authors.forename: Y F
authors.initials: YF
authors.lastname: Kloster
authors.forename: D T
authors.initials: DT
authors.lastname: Kristoffersen
authors.forename: E
authors.initials: E
authors.lastname: Andrew
mesh_terms: D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects*; D004341:Drug Evaluation; D004361:Drug Tolerance; D005060:Europe; D006801:Humans; D014283:Triiodobenzoic Acids / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D003287:Contrast Media; D014283:Triiodobenzoic Acids; C044834:iodixanol